Insider · CIK 0001960742
Mark A. Schallenberger
Files at XTNT (Xtant Medical Holdings, Inc.). First filing -, latest -.
Mark A. Schallenberger files SEC Form 4 as COO at XTNT (Xtant Medical Holdings, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Mark A. Schallenberger has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 15, 2026 | XTNT Xtant Medical Holdings, Inc. | FTax withholding Common Stock | -7,709 | $0.58 | $4,471 | 663,157 | Feb 18, 2026 |
| Nov 15, 2025 | XTNT Xtant Medical Holdings, Inc. | AGrant or award Common Stock | +292,253 | $0.00 | $0 | 670,866 | Nov 18, 2025 |
| Nov 15, 2025 | XTNT Xtant Medical Holdings, Inc. | AGrant or award Performance Stock Units (PSUs)derivative | +584,506 | $0.00 | $0 | 584,506 | Nov 18, 2025 |
Questions about Mark A. Schallenberger
Answered from the filings on this page, as of the latest one.
Is Mark A. Schallenberger buying or selling?
Mark A. Schallenberger has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Mark A. Schallenberger's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mark A. Schallenberger has 0.
Where does Mark A. Schallenberger file Form 4?
Mark A. Schallenberger has filed Form 4 at XTNT (Xtant Medical Holdings, Inc.) as Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.